img

Global Biosynthesis of Cannabinoids Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Biosynthesis of Cannabinoids Market Research Report 2024

Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.
According to MRA Research’s new survey, global Biosynthesis of Cannabinoids market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biosynthesis of Cannabinoids market research.
Key companies engaged in the Biosynthesis of Cannabinoids industry include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of Biosynthesis of Cannabinoids were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole Biosynthesis of Cannabinoids market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biosynthesis of Cannabinoids market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals
Segment by Type
THC
CBD
Others

Segment by Application


Food Industry
Medical Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biosynthesis of Cannabinoids report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 THC
1.2.3 CBD
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosynthesis of Cannabinoids Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Food Industry
1.3.3 Medical Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosynthesis of Cannabinoids Market Perspective (2018-2033)
2.2 Biosynthesis of Cannabinoids Growth Trends by Region
2.2.1 Global Biosynthesis of Cannabinoids Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Biosynthesis of Cannabinoids Historic Market Size by Region (2018-2023)
2.2.3 Biosynthesis of Cannabinoids Forecasted Market Size by Region (2024-2033)
2.3 Biosynthesis of Cannabinoids Market Dynamics
2.3.1 Biosynthesis of Cannabinoids Industry Trends
2.3.2 Biosynthesis of Cannabinoids Market Drivers
2.3.3 Biosynthesis of Cannabinoids Market Challenges
2.3.4 Biosynthesis of Cannabinoids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosynthesis of Cannabinoids Players by Revenue
3.1.1 Global Top Biosynthesis of Cannabinoids Players by Revenue (2018-2023)
3.1.2 Global Biosynthesis of Cannabinoids Revenue Market Share by Players (2018-2023)
3.2 Global Biosynthesis of Cannabinoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosynthesis of Cannabinoids Revenue
3.4 Global Biosynthesis of Cannabinoids Market Concentration Ratio
3.4.1 Global Biosynthesis of Cannabinoids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosynthesis of Cannabinoids Revenue in 2023
3.5 Biosynthesis of Cannabinoids Key Players Head office and Area Served
3.6 Key Players Biosynthesis of Cannabinoids Product Solution and Service
3.7 Date of Enter into Biosynthesis of Cannabinoids Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosynthesis of Cannabinoids Breakdown Data by Type
4.1 Global Biosynthesis of Cannabinoids Historic Market Size by Type (2018-2023)
4.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2024-2033)
5 Biosynthesis of Cannabinoids Breakdown Data by Application
5.1 Global Biosynthesis of Cannabinoids Historic Market Size by Application (2018-2023)
5.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biosynthesis of Cannabinoids Market Size (2018-2033)
6.2 North America Biosynthesis of Cannabinoids Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America Biosynthesis of Cannabinoids Market Size by Country (2018-2023)
6.4 North America Biosynthesis of Cannabinoids Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosynthesis of Cannabinoids Market Size (2018-2033)
7.2 Europe Biosynthesis of Cannabinoids Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe Biosynthesis of Cannabinoids Market Size by Country (2018-2023)
7.4 Europe Biosynthesis of Cannabinoids Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosynthesis of Cannabinoids Market Size (2018-2033)
8.2 Asia-Pacific Biosynthesis of Cannabinoids Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2018-2023)
8.4 Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosynthesis of Cannabinoids Market Size (2018-2033)
9.2 Latin America Biosynthesis of Cannabinoids Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America Biosynthesis of Cannabinoids Market Size by Country (2018-2023)
9.4 Latin America Biosynthesis of Cannabinoids Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosynthesis of Cannabinoids Market Size (2018-2033)
10.2 Middle East & Africa Biosynthesis of Cannabinoids Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2018-2023)
10.4 Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anandia Laboratories
11.1.1 Anandia Laboratories Company Detail
11.1.2 Anandia Laboratories Business Overview
11.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Introduction
11.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.1.5 Anandia Laboratories Recent Development
11.2 Gingko Bioworks
11.2.1 Gingko Bioworks Company Detail
11.2.2 Gingko Bioworks Business Overview
11.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Introduction
11.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.2.5 Gingko Bioworks Recent Development
11.3 Hyasynth Bio
11.3.1 Hyasynth Bio Company Detail
11.3.2 Hyasynth Bio Business Overview
11.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Introduction
11.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.3.5 Hyasynth Bio Recent Development
11.4 InMed Pharmaceuticals
11.4.1 InMed Pharmaceuticals Company Detail
11.4.2 InMed Pharmaceuticals Business Overview
11.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Introduction
11.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.4.5 InMed Pharmaceuticals Recent Development
11.5 Librede
11.5.1 Librede Company Detail
11.5.2 Librede Business Overview
11.5.3 Librede Biosynthesis of Cannabinoids Introduction
11.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.5.5 Librede Recent Development
11.6 Renew Biopharma
11.6.1 Renew Biopharma Company Detail
11.6.2 Renew Biopharma Business Overview
11.6.3 Renew Biopharma Biosynthesis of Cannabinoids Introduction
11.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.6.5 Renew Biopharma Recent Development
11.7 Cronos Group
11.7.1 Cronos Group Company Detail
11.7.2 Cronos Group Business Overview
11.7.3 Cronos Group Biosynthesis of Cannabinoids Introduction
11.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.7.5 Cronos Group Recent Development
11.8 Organigram
11.8.1 Organigram Company Detail
11.8.2 Organigram Business Overview
11.8.3 Organigram Biosynthesis of Cannabinoids Introduction
11.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.8.5 Organigram Recent Development
11.9 Teewinot Life Sciences
11.9.1 Teewinot Life Sciences Company Detail
11.9.2 Teewinot Life Sciences Business Overview
11.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Introduction
11.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.9.5 Teewinot Life Sciences Recent Development
11.10 ICC International Cannabis Corp.
11.10.1 ICC International Cannabis Corp. Company Detail
11.10.2 ICC International Cannabis Corp. Business Overview
11.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Introduction
11.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.10.5 ICC International Cannabis Corp. Recent Development
11.11 Biotii Technologies Corp.
11.11.1 Biotii Technologies Corp. Company Detail
11.11.2 Biotii Technologies Corp. Business Overview
11.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Introduction
11.11.4 Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.11.5 Biotii Technologies Corp. Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Introduction
11.12.4 Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Biogen Inc.
11.13.1 Biogen Inc. Company Detail
11.13.2 Biogen Inc. Business Overview
11.13.3 Biogen Inc. Biosynthesis of Cannabinoids Introduction
11.13.4 Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.13.5 Biogen Inc. Recent Development
11.14 GW Pharmaceuticals
11.14.1 GW Pharmaceuticals Company Detail
11.14.2 GW Pharmaceuticals Business Overview
11.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Introduction
11.14.4 GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.14.5 GW Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of THC
Table 3. Key Players of CBD
Table 4. Key Players of Others
Table 5. Global Biosynthesis of Cannabinoids Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 6. Global Biosynthesis of Cannabinoids Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global Biosynthesis of Cannabinoids Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Biosynthesis of Cannabinoids Market Share by Region (2018-2023)
Table 9. Global Biosynthesis of Cannabinoids Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Biosynthesis of Cannabinoids Market Share by Region (2024-2033)
Table 11. Biosynthesis of Cannabinoids Market Trends
Table 12. Biosynthesis of Cannabinoids Market Drivers
Table 13. Biosynthesis of Cannabinoids Market Challenges
Table 14. Biosynthesis of Cannabinoids Market Restraints
Table 15. Global Biosynthesis of Cannabinoids Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Biosynthesis of Cannabinoids Market Share by Players (2018-2023)
Table 17. Global Top Biosynthesis of Cannabinoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosynthesis of Cannabinoids as of 2023)
Table 18. Ranking of Global Top Biosynthesis of Cannabinoids Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Biosynthesis of Cannabinoids Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biosynthesis of Cannabinoids Product Solution and Service
Table 22. Date of Enter into Biosynthesis of Cannabinoids Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Biosynthesis of Cannabinoids Revenue Market Share by Type (2018-2023)
Table 26. Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Biosynthesis of Cannabinoids Revenue Market Share by Type (2024-2033)
Table 28. Global Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Biosynthesis of Cannabinoids Revenue Market Share by Application (2018-2023)
Table 30. Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Biosynthesis of Cannabinoids Revenue Market Share by Application (2024-2033)
Table 32. North America Biosynthesis of Cannabinoids Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 33. North America Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Biosynthesis of Cannabinoids Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Biosynthesis of Cannabinoids Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 36. Europe Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Biosynthesis of Cannabinoids Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Biosynthesis of Cannabinoids Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 39. Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Biosynthesis of Cannabinoids Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 42. Latin America Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Biosynthesis of Cannabinoids Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Biosynthesis of Cannabinoids Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 45. Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2024-2033) & (US$ Million)
Table 47. Anandia Laboratories Company Detail
Table 48. Anandia Laboratories Business Overview
Table 49. Anandia Laboratories Biosynthesis of Cannabinoids Product
Table 50. Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 51. Anandia Laboratories Recent Development
Table 52. Gingko Bioworks Company Detail
Table 53. Gingko Bioworks Business Overview
Table 54. Gingko Bioworks Biosynthesis of Cannabinoids Product
Table 55. Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 56. Gingko Bioworks Recent Development
Table 57. Hyasynth Bio Company Detail
Table 58. Hyasynth Bio Business Overview
Table 59. Hyasynth Bio Biosynthesis of Cannabinoids Product
Table 60. Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 61. Hyasynth Bio Recent Development
Table 62. InMed Pharmaceuticals Company Detail
Table 63. InMed Pharmaceuticals Business Overview
Table 64. InMed Pharmaceuticals Biosynthesis of Cannabinoids Product
Table 65. InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 66. InMed Pharmaceuticals Recent Development
Table 67. Librede Company Detail
Table 68. Librede Business Overview
Table 69. Librede Biosynthesis of Cannabinoids Product
Table 70. Librede Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 71. Librede Recent Development
Table 72. Renew Biopharma Company Detail
Table 73. Renew Biopharma Business Overview
Table 74. Renew Biopharma Biosynthesis of Cannabinoids Product
Table 75. Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 76. Renew Biopharma Recent Development
Table 77. Cronos Group Company Detail
Table 78. Cronos Group Business Overview
Table 79. Cronos Group Biosynthesis of Cannabinoids Product
Table 80. Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 81. Cronos Group Recent Development
Table 82. Organigram Company Detail
Table 83. Organigram Business Overview
Table 84. Organigram Biosynthesis of Cannabinoids Product
Table 85. Organigram Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 86. Organigram Recent Development
Table 87. Teewinot Life Sciences Company Detail
Table 88. Teewinot Life Sciences Business Overview
Table 89. Teewinot Life Sciences Biosynthesis of Cannabinoids Product
Table 90. Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 91. Teewinot Life Sciences Recent Development
Table 92. ICC International Cannabis Corp. Company Detail
Table 93. ICC International Cannabis Corp. Business Overview
Table 94. ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product
Table 95. ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 96. ICC International Cannabis Corp. Recent Development
Table 97. Biotii Technologies Corp. Company Detail
Table 98. Biotii Technologies Corp. Business Overview
Table 99. Biotii Technologies Corp. Biosynthesis of Cannabinoids Product
Table 100. Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 101. Biotii Technologies Corp. Recent Development
Table 102. Bristol-Myers Squibb Company Detail
Table 103. Bristol-Myers Squibb Business Overview
Table 104. Bristol-Myers Squibb Biosynthesis of Cannabinoids Product
Table 105. Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 106. Bristol-Myers Squibb Recent Development
Table 107. Biogen Inc. Company Detail
Table 108. Biogen Inc. Business Overview
Table 109. Biogen Inc. Biosynthesis of Cannabinoids Product
Table 110. Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 111. Biogen Inc. Recent Development
Table 112. GW Pharmaceuticals Company Detail
Table 113. GW Pharmaceuticals Business Overview
Table 114. GW Pharmaceuticals Biosynthesis of Cannabinoids Product
Table 115. GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 116. GW Pharmaceuticals Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosynthesis of Cannabinoids Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Biosynthesis of Cannabinoids Market Share by Type: 2023 VS 2033
Figure 3. THC Features
Figure 4. CBD Features
Figure 5. Others Features
Figure 6. Global Biosynthesis of Cannabinoids Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Biosynthesis of Cannabinoids Market Share by Application: 2023 VS 2033
Figure 8. Food Industry Case Studies
Figure 9. Medical Industry Case Studies
Figure 10. Others Case Studies
Figure 11. Biosynthesis of Cannabinoids Report Years Considered
Figure 12. Global Biosynthesis of Cannabinoids Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Biosynthesis of Cannabinoids Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 14. Global Biosynthesis of Cannabinoids Market Share by Region: 2023 VS 2033
Figure 15. Global Biosynthesis of Cannabinoids Market Share by Players in 2023
Figure 16. Global Top Biosynthesis of Cannabinoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosynthesis of Cannabinoids as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Biosynthesis of Cannabinoids Revenue in 2023
Figure 18. North America Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Biosynthesis of Cannabinoids Market Share by Country (2018-2033)
Figure 20. United States Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Biosynthesis of Cannabinoids Market Share by Country (2018-2033)
Figure 24. Germany Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Biosynthesis of Cannabinoids Market Share by Region (2018-2033)
Figure 32. China Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Biosynthesis of Cannabinoids Market Share by Country (2018-2033)
Figure 40. Mexico Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Biosynthesis of Cannabinoids Market Share by Country (2018-2033)
Figure 44. Turkey Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Anandia Laboratories Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 47. Gingko Bioworks Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 48. Hyasynth Bio Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 49. InMed Pharmaceuticals Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 50. Librede Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 51. Renew Biopharma Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 52. Cronos Group Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 53. Organigram Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 54. Teewinot Life Sciences Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 55. ICC International Cannabis Corp. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 56. Biotii Technologies Corp. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 58. Biogen Inc. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 59. GW Pharmaceuticals Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed